Before an oral dewormer can kill parasites, it has to dissolve. But new research suggests that step may not always happen as efficiently as expected. In laboratory testing, a commercial oxfendazole tablet released only about 10% of its drug content, prompting researchers to explore new formulations designed to improve dissolution and extend drug exposure in cattle.
Bezerra and colleagues at the Dundalk Institute of Technology in Ireland explored whether reformulating the common benzimidazole dewormer oxfendazole could improve both dissolution and the duration of drug exposure in cattle. The findings highlight an important point: how a drug is formulated can influence how well it works.
The Hidden Step in Deworming: Why Dissolution Matters in Cattle
When an oral anthelmintic is given to cattle, the drug must first dissolve in gastrointestinal fluids before it can be absorbed or interact with parasites in the digestive tract. For drugs like oxfendazole, that step can be difficult. Benzimidazole anthelmintics are poorly soluble in water, which can limit how quickly and completely they dissolve.
In dissolution testing designed to simulate acidic abomasal conditions, researchers found a commercial oxfendazole tablet released only about 10% of its drug content.
Laboratory dissolution tests do not perfectly replicate conditions in cattle. But the pharmacologic principle still applies: if a drug does not dissolve, it cannot be absorbed effectively. For parasites that require sustained exposure to a drug, incomplete dissolution may limit treatment effectiveness.
Why Drug Delivery Is Challenging for Oral Dewormers in Cattle
Delivering drugs to ruminants is more complicated than in monogastric animals. After administration, an oral drug passes through several very different digestive environments. The rumen and reticulum operate near neutral pH, while the abomasum is strongly acidic. The drug then moves into the intestines, where pH gradually rises again.
Several factors can influence how much drug ultimately becomes available to affect parasites:
- Rumen dilution, which can disperse oral drugs before they dissolve
- Shifting pH environments throughout the digestive tract
- Gastrointestinal transit time, which determines how long drugs remain available for absorption
- Enterohepatic recycling, where drug excreted in bile re-enters the digestive tract
Many gastrointestinal parasites are exposed to anthelmintics through both systemic drug levels and the drug moving through the digestive tract itself. Because of this, the timing and extent of drug release can influence parasite exposure.
Rebuilding the Tablet: New Formulations for Oxfendazole
To address the dissolution problem, researchers developed experimental oxfendazole tablets using two advanced pharmaceutical manufacturing techniques: hot-melt extrusion and microinjection molding.
These techniques embed the drug within polymer matrices, converting it from a crystalline form to an amorphous structure. Amorphous drugs typically dissolve more readily, improving bioavailability.
In laboratory testing, one experimental formulation released nearly 90% of the drug during dissolution testing, an eightfold improvement compared with the commercial tablet.
The formulation used polyethylene oxide as the primary polymer carrier. When exposed to fluid, the polymer swells, allowing water to penetrate the tablet and gradually release the drug.
The result was substantially more active drug becoming available in the simulated gastrointestinal environment.
Extending Drug Exposure in Cattle
Researchers also explored whether tablet design could extend how long the drug is released in the digestive tract. A second formulation incorporated polycaprolactone along with polyethylene oxide, producing a slower-eroding polymer matrix. As fluid enters the tablet, pores gradually form within the polymer structure, allowing the drug to diffuse outward over time.
In dissolution testing, this formulation released drug gradually over about three days, roughly matching the typical 72-hour gastrointestinal transit time in cattle.
For parasite control, a slow-release system could potentially maintain drug exposure longer and improve efficacy against parasites that require sustained exposure.
Safety Considerations
Because cattle are food-producing animals, both the active drug and formulation components must be safe.
The study evaluated the polymer formulations using liver cell cultures. At concentrations consistent with expected exposure, the materials used in the tablets did not demonstrate cytotoxic effects.
Polymers such as polyethylene oxide are widely used in pharmaceutical formulations because they are biologically inert, stable during processing and compatible with controlled-release drug systems.
What It Could Mean for Parasite Control in Cattle
While the results are promising, the research remains at an early stage. Field trials would be needed to determine whether improved dissolution and controlled-release properties translate into better parasite control in cattle.
Still, the findings highlight an often-overlooked factor in deworming success. The effectiveness of an anthelmintic depends not only on the drug itself, but also on how it is delivered in the animal.
